Guided VCTE: A New Era in Liver Health Diagnostics

In the second episode of "Liver Health Shaper," join host Victor de Lédinghen, Chief Medical Officer at Echosens, as he dives into the groundbreaking advancements in liver health diagnostics with the next-generation FibroScan equipped with Guided VCTE technology. This episode features enlightening discussions with Dr. Raj Vuppalanchi, a hepatologist and Professor of Medicine at Indiana University School of Medicine, and Louise Campbell, Founder and Clinical Director at Tawazun Health. Together, they explore how this innovative technology enhances the accuracy and efficiency of liver assessments. They also discuss the critical role of non-invasive tools in managing and preventing widespread liver conditions such as MASLD and MASH, the potential hurdles in integrating these technologies into standard practice, and their impact on patient identification and treatment monitoring amidst evolving therapeutic landscapes.Guests:- Dr. Raj Vuppalanchi, Director of Hepatology at Indiana University School of Medicine- Louise Campbell, Founder and Clinical Director at Tawazun HealthTopics covered in the episode:- Introduction to the new Guided VCTE technology in FibroScan- Enhancements in diagnostic efficiency and accuracy- Impact on clinical workflow and decision-making- Role of non-invasive tools in the prevention and management of liver diseases- Future challenges and opportunities in liver health management- Influence on patient identification, access, and treatment monitoring in light of new drug approvalsHosted on Ausha. See ausha.co/privacy-policy for more information.